A circulating biomarker for use in monitoring metastatic breast cancer
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43CA210817
- Recipient
-
A&G Pharmaceutical, Inc. UEI SN6SWFABJXL1
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $152,589
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Place of performance
- Columbia, MD 21045, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $152,589 |
Quick answers
Who received award R43CA210817?
R43CA210817 was awarded to A&G Pharmaceutical, Inc. by National Institutes of Health (Department of Health and Human Services) on March 15, 2017.
How much is award R43CA210817 worth?
$152,589 has been obligated on R43CA210817.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award